62 related articles for article (PubMed ID: 32266805)
1. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea.
Ha HI; Kim JH; Lim J; Song YJ; Won YJ; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e31. PubMed ID: 38072401
[TBL] [Abstract][Full Text] [Related]
2. Identification of fallopian tube microbiota and its association with ovarian cancer.
Yu B; Liu C; Proll SC; Manhardt E; Liang S; Srinivasan S; Swisher E; Fredricks DN
Elife; 2024 Mar; 12():. PubMed ID: 38451065
[TBL] [Abstract][Full Text] [Related]
3. Identification of fallopian tube microbiota and its association with ovarian cancer: a prospective study of intraoperative swab collections from 187 patients.
Yu B; Liu C; Proll S; Mannhardt E; Liang S; Srinivasan S; Swisher E; Fredricks DN
medRxiv; 2023 Nov; ():. PubMed ID: 37425928
[TBL] [Abstract][Full Text] [Related]
4. Follicular fluid aids cell adhesion, spreading in an age independent manner and shows an age-dependent effect on DNA damage in fallopian tube epithelial cells.
Salvi A; Li W; Dipali SS; Cologna SM; Pavone ME; Duncan FE; Burdette JE
Heliyon; 2024 Mar; 10(6):e27336. PubMed ID: 38501015
[TBL] [Abstract][Full Text] [Related]
5. Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry.
Yun BS; Park EH; Ha J; Lee JY; Lee KH; Lee TS; Lee KJ; Kim YJ; Jung KW; Roh JW
Obstet Gynecol Sci; 2023 Nov; 66(6):545-561. PubMed ID: 37953552
[TBL] [Abstract][Full Text] [Related]
6. HOXA‑AS3 induces tumor progression through the epithelial‑mesenchymal transition pathway in epithelial ovarian cancer.
Eoh KJ; Lee DW; Nam EJ; Kim JI; Moon H; Kim SW; Kim YT
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799173
[TBL] [Abstract][Full Text] [Related]
7. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.
Levine DA; Argenta PA; Yee CJ; Marshall DS; Olvera N; Bogomolniy F; Rahaman JA; Robson ME; Offit K; Barakat RR; Soslow RA; Boyd J
J Clin Oncol; 2003 Nov; 21(22):4222-7. PubMed ID: 14615451
[TBL] [Abstract][Full Text] [Related]
8. Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999-2016: a retrospective study based on the Korean National Cancer Incidence Database.
Shin W; Won YJ; Yoo CW; Lim J; Lim MC
J Gynecol Oncol; 2020 Jul; 31(4):e56. PubMed ID: 32266805
[TBL] [Abstract][Full Text] [Related]
9. Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
Weiss AS; Swisher E; Pennington KP; Radke M; Khasnavis N; Garcia RL; Kilgore MR; Lee MK; Norquist BM
Gynecol Oncol; 2020 Oct; 159(1):214-220. PubMed ID: 32709535
[TBL] [Abstract][Full Text] [Related]
10. Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry.
Ha HI; Lee EG; Lim J; Jung SY; Chang YJ; Won YJ; Lim MC
Cancer Res Treat; 2021 Apr; 53(2):541-548. PubMed ID: 33211942
[TBL] [Abstract][Full Text] [Related]
11. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
Cortesi L; De Matteis E; Toss A; Marchi I; Medici V; Contu G; Xholli A; Grandi G; Cagnacci A; Federico M
Oncology; 2017; 93(6):377-386. PubMed ID: 28848147
[TBL] [Abstract][Full Text] [Related]
13. Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Kerliu L; Myruski S; Bhatti A; Soni P; Petrosius P; Pervanas HC; Horton ER
Ann Pharmacother; 2020 Oct; 54(10):1010-1015. PubMed ID: 32172572
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
